https://www.biospace.com/enzon-pharmaceuticals-inc-announces-effectiveness-of-form-s-3-registration-statement
Enzon Pharmaceuticals, Inc. Announces Effectiveness Of Form S-3 Registration Statement - BioSpace
form s 3enzon pharmaceuticals
https://www.biospace.com/enzon-pharmaceuticals-inc-opens-a-phase-2-study-of-peg-sn38-for-metastatic-breast-cancer
Enzon Pharmaceuticals, Inc. Opens a Phase 2 Study of PEG-SN38 for Metastatic Breast Cancer -...